In a randomized, controlled clinical trial, 137 women who experienced two or more UTIs treated with antibiotic in the previous 12 months were selected to receive either 500 mg of Cran-Max® or 100 mg of trimethoprim per day for six months. The researchers found that the time of rst recurrence of the UTI was not signi cantly different between groups. The researchers concluded that in the rst head-to-head, double-blind comparison of cranberry versus antibiotic prophylaxis, trimethoprim had a very limited advantage over Cran-Max in the prevention of recurrent UTIs in older women, while Cran-Max produced none of the adverse effects associated with trimethoprim, including diarrhea, upset stomach and yeast infection. In addition, trimethoprim is contraindicated for warfarin and should not be taken together.

UtyMax® is a medical food. Use under supervision of a quali ed healthcare professional.